Substance-specific environmental influences on drug use and drug preference in animals and humans

Current Opinion in Neurobiology

Volumn 23, Issue 4, 2013, Pages 588-596

  Badiani, Aldo ^a,b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF SUSSEX   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; DIAMORPHINE;

ANATOMICAL VARIATION; AROUSAL; BRAIN REGION; DRUG ABUSE; DRUG DEPENDENCE; DRUG PREFERENCE; EMOTIONALITY; ENVIRONMENTAL FACTOR; EXECUTIVE FUNCTION; HUMAN; NEUROANATOMY; NEUROPHYSIOLOGY; NONHUMAN; PRIORITY JOURNAL; REVIEW; REWARD; RISK ASSESSMENT; RISK FACTOR;

EID: 84881024387     PISSN: 09594388     EISSN: 18736882     Source Type: Journal    
DOI: 10.1016/j.conb.2013.03.010     Document Type: Review

References (79)

1. Di Chiara G., Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci U S A 1988, 85:5274-5278.
2. Johanson C.E., Fischman M.W. The pharmacology of cocaine related to its abuse. Pharmacol Rev 1989, 41:3-52.
3. Gysling K., Wang R.Y. Morphine-induced activation of A10 dopamine neurons in the rat. Brain Res 1983, 277:119-127.
4. Johnson S.W., North R.A. Opioids excite dopamine neurons by hyperpolarization of local interneurons. J Neurosci 1992, 12:483-488.
5. Berridge K.C. From prediction error to incentive salience: mesolimbic computation of reward motivation. Eur J Neurosci 2012, 35:1124-1143.
6. Wise R.A. Roles for nigrostriatal-not just mesocorticolimbic-dopamine in reward and addiction. Trends Neurosci 2009, 32:517-524.
7. Robinson T.E., Berridge K.C. The incentive sensitization theory of addiction: some current issues. Philos Trans R Soc Lond B Biol Sci 2008, 363:3137-3146.
8. Robison A.J., Nestler E.J. Transcriptional and epigenetic mechanisms of addiction. Nat Rev Neurosci 2011, 12:623-637.
9. Kalivas P.W., Volkow N.D. New medications for drug addiction hiding in glutamatergic neuroplasticity. Mol Psychiatry 2011, 16:974-986.
10. Collins E.D., Kleber H.D. Opioids: detoxification. Textbook of Substance Abuse Treatment 2004, 55-72. The American Psychiatric Publishing, Arlington, VA, USA. M. Galanter, H.D. Kleber (Eds.).
11. Amato L., Minozzi S., Pani P.P., Solimini R., Vecchi S., Zuccaro P., Davoli M. Dopamine agonists for the treatment of cocaine dependence. Cochrane Database Syst Rev 2011, 7. CD003352.
12. Kendler K.S., Jacobson K.C., Prescott C.A., Neale M.C. Specificity of genetic and environmental risk factors for use and abuse/dependence of cannabis, cocaine, hallucinogens, sedatives, stimulants, and opiates in male twins. Am J Psychiatry 2003, 160:687-695.
13. Tsuang M.T., Lyons M.J., Meyer J.M., Doyle T., Eisen S.A., Goldberg J., True W., Lin N., Toomey R., Eaves L. Co-occurrence of abuse of different drugs in men. Arch Gen Psychiatry 1998, 55:967-972.
14. Merikangas K., Stolar M., Stevens D.E., Goulet J., Preisig M.A., Fenton B., Zhang H., O'Malley S.S., Rounsaville B.J. Familial transmission of substance use disorders. Arch Gen Psychiatry 1998, 55:973-979.
15. Karkowski L.M., Prescott C.A., Kendler K.S. Multivariate assessment of factors influencing illicit substance use in twins from female-female pairs. Am J Med Genet Neuropsychiatr Genet 2000, 96:665-670.
16. Agrawal A., Lynskey M.T. The genetic epidemiology of cannabis use, abuse and dependence. Addiction 2006, 101:801-812.
17. Lynskey M.T., Agrawal A., Heath A.C. Genetically informative research on adolescent substance use: methods, findings, and challenges. J Am Acad Child Adolesc Psychiatry 2010, 49:1202-1214.
18. Bierut L.J., Dinwiddie S.H., Begleiter H., Crowe R.R., Hesselbrock V., Nurnberger J.I., Porjesz B., Schuckit M., Reich T. Familial transmission of substance dependence: alcohol, marijuana, cocaine, and habitual smoking. Arch Gen Psychiatry 1998, 55:982-988.
19. Badiani A., Belin D., Epstein D., Calu D., Shaham Y. Opiate versus psychostimulant addiction: the differences do matter. Nat Rev Neurosci 2011, 12:685-700.
20. Koob G., Kreek M.J. Stress, dysregulation of drug reward pathways, and the transition to drug dependence. Am J Psychiatry 2007, 164:1149-1159.
21. Caprioli D., Celentano M., Paolone G., Badiani A. Modeling the role of environment in addiction. Prog Neuropsychopharmacol Biol Psychiatry 2007, 31:1639-1653.
22. Sinha R. Modeling stress and drug craving in the laboratory: implications for addiction treatment development. Addict Biol 2009, 14:84-98.
23. Crombag H.S., Bossert J.M., Koya E., Shaham Y. Context-induced relapse to drug seeking: a review. Philos Trans R Soc Lond B Biol Sci 2008, 363:3233-3243.
24. Caprioli D., Celentano M., Dubla A., Lucantonio F., Nencini P., Badiani A. Ambience and drug choice: cocaine- and heroin-taking as a function of environmental context in humans and rats. Biol Psychiatry 2009, 65:893-899.
25. Badiani A, Spagnolo AP: Role of environmental factors in cocaine addiction. Curr Pharm Des 2013, in press.
26. Caprioli D., Paolone G., Celentano M., Testa A., Nencini P., Badiani A. Environmental modulation of cocaine self-administration in the rat. Psychopharmacology (Berl) 2007, 192:397-406.
27. Caprioli D., Celentano M., Paolone G., Lucantonio F., Bari A., Nencini P., Badiani A. Opposite environmental regulation of heroin and amphetamine self-administration in the rat. Psychopharmacology (Berl) 2008, 198:395-404.
28. Celentano M., Caprioli D., Dipasquale P., Cardillo V., Nencini P., Gaetani S., Badiani A. Drug context differently regulates cocaine versus heroin self-administration and cocaine- versus heroin-induced Fos mRNA expression in the rat. Psychopharmacology (Berl) 2009, 204:349-360.
29. Billman G.E. Cocaine: a review of its toxic actions on cardiac function. Crit Rev Toxicol 1995, 25:113-132.
30. Sofuoglu M., Sewell R.A. Norepinephrine and stimulant addiction. Addict Biol 2009, 14:119-129.
31. Haddad G.G., Lasala P.A. Effect of parasympathetic blockade on ventilatory and cardiac depression induced by opioids. Respir Physiol 1987, 67:101-114.
32. Thornhill J.A., Townsend C., Gregor L. Intravenous morphine infusion (IMF) to drug-naive, conscious rats evokes bradycardic, hypotensive effects, but pressor actions are elicited after IMF to rats previously given morphine. Can J Physiol Pharmacol 1989, 67:213-222.
33. James W., Lange C.G. The Emotions 1922, Williams & Wilkins Co., Baltimore, MD, USA.
34. Valins S. Cognitive effects of false heart-rate feedback. J Pers Soc Psychol 1966, 4:400-408.
35. Valins S: Citation Classic Commentaries in Current Content. 1986:23 (). http://www.garfield.library.upenn.edu/classics1986/A1986C497400001.pdf.
36. Gray M.A., Harrison N.A., Wiens S., Critchley H.D. Modulation of emotional appraisal by false physiological feedback during fMRI. PLoS ONE 2007, 2:e546.
37. Gray M.A., Beacher F.D., Minati L., Nagai Y., Kemp A.H., Harrison N.A., Critchley H.D. Emotional appraisal is influenced by cardiac afferent information. Emotion 2012, 12:180-191.
38. Critchley H.D. Psychophysiology of neural, cognitive and affective integration: fMRI and autonomic indicants. Int J Psychophysiol 2009, 73:88-94.
39. Zajonc R.B. Feeling and thinking: preferences need no inferences. Am Psychol 1980, 31:151-175.
40. LeDoux J.E. Rethinking the emotional brain. Neuron 2012, 73:653-676.
41. Nyaronga D., Greenfield T.K., McDaniel P.A. Drinking context and drinking problems among black, white, and Hispanic men and women in the 1984, 1995, and 2005 U.S. National Alcohol Surveys. J Stud Alcohol Drugs 2009, 70:16-26.
42. Testa A., Nencini P., Badiani A. The role of setting in the oral self-administration of alcohol in the rat. Psychopharmacology (Berl) 2011, 215:749-760.
43. De Luca M.T., Badiani A. Ketamine self-administration in the rat: evidence for a critical role of setting. Psychopharmacology (Berl) 2011, 214:549-556.
44. De Luca M.T., Meringolo M., Spagnolo P.A., Badiani A. The role of setting for ketamine abuse: clinical and preclinical evidence. Rev Neurosci 2012, 23:769-780.
45. Dillon P., Copeland J., Jansen K. Patterns of use and harms associated with non-medical ketamine use. Drug Alcohol Depend 2003, 69:23-28.
46. Sah P., Faber E.S., Lopez De Armentia M., Power J. The amygdaloid complex: anatomy and physiology. Physiol Rev 2003, 83:803-834.
47. McDonald A.J. Topographical organization of amygdaloid projections to the caudatoputamen, nucleus accumbens, and related striatal-like areas of the rat brain. Neuroscience 1991, 44:15-33.
48. Salzman C.D., Fusi S. Emotion, cognition, and mental state representation in amygdala and prefrontal cortex. Annu Rev Neurosci 2010, 33:173-202.
49. Murray E.A. The amygdala, reward and emotion. Trends Cogn Sci 2007, 11:489-497.
50. Tamietto M., de Gelder B. Neural bases of the non-conscious perception of emotional signals. Nat Rev Neurosci 2010, 11:697-709.
51. Critchley H.D., Harrison N.A. Visceral influences on brain and behavior. Neuron 2013, 77:624-638.
52. Di Ciano P., Everitt B.J. Direct interactions between the basolateral amygdala and nucleus accumbens core underlie cocaine-seeking behavior by rats. J Neurosci 2004, 24:7167-7173.
53. Ambroggi F., Ishikawa A., Fields H.L., Nicola S.M. Basolateral amygdala neurons facilitate reward-seeking behavior by exciting nucleus accumbens neurons. Neuron 2008, 59:648-661.
54. Britt J.P., Benaliouad F., McDevitt R.A., Stuber G.D., Wise R.A., Bonci A. Synaptic and behavioral profile of multiple glutamatergic inputs to the nucleus accumbens. Neuron 2012, 76:790-803.
55. Stuber G.D., Sparta D.R., Stamatakis A.M., van Leeuwen W.A., Hardjoprajitno J.E., Cho S., Tye K.M., Kempadoo K.A., Zhang F., Deisseroth K., Bonci A. Excitatory transmission from the amygdala to nucleus accumbens facilitates reward seeking. Nature 2011, 475:377-780.
56. Prado-Alcalá R., Wise R.A. Brain stimulation reward and dopamine terminal fields. I. Caudate-putamen, nucleus accumbens and amygdala. Brain Res 1984, 297:265-273.
57. Kane F., Coulombe D., Miliaressis E. Amygdaloid self-stimulation: a movable electrode mapping study. Behav Neurosci 1991, 105:926-932.
58. David V., Cazala P. A comparative study of self-administration of morphine into the amygdala and the ventral tegmental area in mice. Behav Brain Res 1994, 65:205-211.
59. Fuchs R.A., See R.E. Basolateral amygdala inactivation abolishes conditioned stimulus- and heroin-induced reinstatement of extinguished heroin-seeking behavior in rats. Psychopharmacology (Berl) 2002, 160:425-433.
60. Yun I.A., Fields H.L. Basolateral amygdala lesions impair both cue- and cocaine-induced reinstatement in animals trained on a discriminative stimulus task. Neuroscience 2003, 121:747-757.
61. Dong H.W., Petrovich G.D., Swanson L.W. Topography of projections from amygdala to bed nuclei of the stria terminalis. Brain Res Brain Res Rev 2001, 38:192-246.
62. Hitchcock J.M., Davis M. Lesions of the amygdala, but not of the cerebellum or red nucleus, block conditioned fear as measured with the potentiated startle paradigm. Behav Neurosci 1986, 100:11-22.
63. Somerville L.H., Whalen P.J., Kelley W.M. Human bed nucleus of the stria terminalis indexes hypervigilant threat monitoring. Biol Psychiatry 2010, 68:416-424.
64. Frenois F., Cador M., Caillé S., Stinus L., Le Moine C. Neural correlates of the motivational and somatic components of naloxone-precipitated morphine withdrawal. Eur J Neurosci 2002, 16:1377-1389.
65. Howland J.G., Taepavarapruk P., Phillips A.G. Glutamate receptor-dependent modulation of dopamine efflux in the nucleus accumbens by basolateral, but not central, nucleus of the amygdala in rats. J Neurosci 2002, 22:1137-1145.
66. Badiani A., Oates M.M., Day H.E., Watson S.J., Akil H., Robinson T.E. Amphetamine-induced behavior, dopamine release, and c-fos mRNA expression: modulation by environmental novelty. J Neurosci 1998, 18:10579-10593.
67. Badiani A., Oates M.M., Day H.E., Watson S.J., Akil H., Robinson T.E. Environmental modulation of amphetamine-induced c-fos expression in D1 versus D2 striatal neurons. Behav Brain Res 1999, 103:203-209.
68. Badiani A., Oates M.M., Fraioli S., Browman K.E., Ostrander M.M., Xue C.J., Wolf M.E., Robinson T.E. Environmental modulation of the response to amphetamine: dissociation between changes in behavior and changes in dopamine and glutamate overflow in the rat striatal complex. Psychopharmacology (Berl) 2000, 151:166-174.
69. Day H.E., Badiani A., Uslaner J.M., Oates M.M., Vittoz N.M., Robinson T.E., Watson S.J., Akil H. Environmental novelty differentially affects c-fos mRNA expression induced by amphetamine or cocaine in subregions of the bed nucleus of the stria terminalis and amygdala. J Neurosci 2001, 21:732-740.
70. Uslaner J., Badiani A., Norton C.S., Day H.E., Watson S.J., Akil H., Robinson T.E. Amphetamine and cocaine induce different patterns of c-fos mRNA expression in the striatum and subthalamic nucleus depending on environmental context. Eur J Neurosci 2001, 13:1977-1983.
71. Ostrander M.M., Badiani A., Day H.E., Norton C.S., Watson S.J., Akil H., Robinson T.E. Environmental context and drug history modulate amphetamine-induced c-fos mRNA expression in the basal ganglia, central extended amygdala, and associated limbic forebrain. Neuroscience 2003, 120:551-571.
72. Badiani A., Robinson T.E. Drug-induced neurobehavioral plasticity: the role of environmental context. Behav Pharmacol 2004, 15:327-339.
73. Ikemoto S. Brain reward circuitry beyond the mesolimbic dopamine system: a neurobiological theory. Neurosci Biobehav Rev 2010, 35:129-150.
74. Ersche K.D., Sahakian B.J. The neuropsychology of amphetamine and opiate dependence: implications for treatment. Neuropsychol Rev 2007, 17:317-336.
75. Gorodetzky H., Sahakian B.J., Robbins T.W., Ersche K.D. Differences in self-reported decision-making styles in stimulant-dependent and opiate-dependent individuals. Psychiatry Res 2011, 186:437-440.
76. Martinez D., Saccone P.A., Liu F., Slifstein M., Orlowska D., Grassetti A., Cook S., Broft A., Van Heertum R., Comer S.D. Deficits in dopamine D(2) receptors and presynaptic dopamine in heroin dependence: commonalities and differences with other types of addiction. Biol Psychiatry 2012, 71:192-198.
77. Daglish M.R.C., Williams T.R., Wilson S.J., Taylor L.G., Eap C.B., Augsburger M., Giroud, Brooks D.J., Myles J.S., Grasby P., Lingford-Hughes A.R., Nutt D.J. Brain dopamine response in human heroin addiction. Brit J Psychiatry 2008, 193:1-6.
78. Heron K.E., Smyth J.M. Ecological momentary interventions: incorporating mobile technology into psychosocial and health behaviour treatments. Br J Health Psychol 2010, 15:1-39.
79. Waters A.J., Marhe R., Franken I.H.A. Attentional bias to drug cues is elevated before and during temptations to use heroin and cocaine. Psychopharmacology (Berl) 2012, 219:909-921.